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The appearance of resistances in bacteria is an evolutionary phenomena, although the excessive
exposure to antibiotics makes it a growing problem1 . There is a group of bacteria called ESKAPE,
which comprises Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii,
Pseudomonas aeruginosa and Enterobacteriaceae species, that is very problematic in community and hospital
settings due to their resistance to multiple antibiotics; they have been considered by the Infectious
Diseases Society of America (IDSA) as priority targets for antimicrobial research2.
The increase and continuous spread of resistances lead to the necessity of new compounds for the
treatment of bacterial infections. However, there has been a lack of new antibiotics since the 1980s3. This
fact and the appearance of new antibiotic-resistant bacteria has encourage the search of new techniques
to solve the problem.
Bacteriophages are proposed as a potential tool for treating infectious diseases as they are bacterial
viruses that replicate exponentially until the death of bacteria4.
Objective: To perform a comparative analysis (critical points of phage therapy and advantages in front of
antibiotics) and show some examples of phage therapy.
Table 1: Comparison between antibiotics and bacteriophages
Characteristic Antibiotics Bacteriophages
Host specificity6 Broad Narrow
Solved infections5
Difficult infections are 
not solved
Difficult infections: biofilms, 
persisters, antibiotic resistant 
bacteria
Side effects5
Affect normal 
microflora
No serious but possible 
release of endotoxins
Concentration in 
time6
Decrease
Eliminated from the 
body
Self-regulating tools
Multiplication in presence of 
host bacteria
Decrease when bacteria are 
eliminated
Synthesis6
Synthetics or 
semisynthetics
Ecologically pure
Isolation and 
characterization of 
new phages5
Slower and more 
expensive
Faster and cheaper
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Example 14
Bacteria: S. aureus
Bacteriophage: ФMR11
Organism: mice
Result: 
• 80% untreated mice died
within 24 hours post-infection
• Mice treated instantly after
infection were protected.
• Immune response not implied
• Phage disappear after
elimination of bacteria
Efficacy
Just few bacteriophages are
efficient as therapeutic
agents6.
Phage choice Pharmacokinetics
Critical parameters: absorption rate, burst size, latent period, initial phage
dose, density and clearance rate of the phage particles from the body fluids by
the reticuloendothelial system (RES) 4.
Solution to the clearance by RES:
Bacterial resistances to bacteriophages
Bacterial resistances can appear by many mechanisms
Avoidance: cocktail of phages or phage + antibiotic6
Phage manufacturing
Toxicity
Approach to reduce toxicity5:
Interaction with 
non-target tissue
Phages can interact with
non-target tissue, although
these interactions do not
produce side effects7.
CRITICAL POINTS OF PHAGE THERAPY
ADVANTAGES
Figure 1: Phage therapy requires the presence of infective bacteria in a patient and
bacteriophages that kill this bacterium species. Bacteriophages are administrated to the
patient (the way of administration depends on the infection). Bacteriophages arrive to
bacteria and start their cycle. They replicate and provoke bacterial lysis. Then, the released
bacteriophages can infect other bacteria and repeat the process.
Figure 3: Cocktail of bacteriophages. The
use of different phages simultaneously
allows targeting a wider number of bacterial
species. Modified from [5].
Figure 4: Modification of bacteriophages by (a) directed evolution or (b) addition of a coat, so
as to avoid the inactivation and clearance. Modified from [5].
Figure 2: Cellular toxins (LPS: Lipopolysaccharide, SA:
superantigen) can be released during cell lysis and
provoke systemic inflammatory responses and increase
morbidity and mortality. Modified from [5].
1. Individual phage chosen by isolation 
of infectious pathogen
2. Cocktail of phages6
Engineered phages 
deficient in lysins
and/or non-replicative
Reduce endotoxins +
Inflammation mediators
Example 25
Bacteria: Pseudomonas
Bacteriophage: cocktail
Infection: chronic otitis
Organism: adult humans
Result: decrease in Pseudomonas loads
Other example 
(No ESKAPE)8
Bacteria: Salmonella enterica
Bacteriophage: cocktail
Organism: chicken and mice
Result: reduction of bacteria was
obtained when animals were
treated frequently and especially,
before the infection of Salmonella
a b
Example 34
Bacteria: vancomycin-resistant 
E. faecium
Bacteriophage: ENB6
Organism: mouse model
Result: administration between 45
minutes and 5 hours after the
infection saved all mice.
Example 47
Bacteria: P. aeruginosa & S. aureus
Bacteriophage: Pyophage & Sb-I
Infection: respiratory infection
Organism: seven-year old patient
Result: both infections removed
Figure 5: Bacteriophage manufacture has
multiple steps: production, purification,
formulation, quality control, among others. The
process is complicated as the cell lysis releases
endotoxins and other cellular toxins and by the
need of multi-phage cocktails. Modified from [5].
